The Emory CCPDER can take advantage of its experience with the Emory Alzheimer's Disease Center (ADC). The ADC has been soliciting, reviewing and funding 2-3 pilots per year, and Drs. Greenamyre and Levey (principal investigator of the ADC) have been instrumental in this process. In the fall of each year, invitations to submit proposals will be sent electronically to the faculty, and notices will be distributed in flyers and several widely read University publications. Memos also will be sent to all faculty on the CND mailing and seminar notice lists. Junior investigators and established investigators working in other research areas will be encouraged to apply. The investigators believe pilot projects should be intended to allow investigators the opportunity to develop preliminary data sufficient to provide the basis for subsequent independent research support through conventional granting mechanisms. The application will be limited to no more that 5 pages, using a truncated NIH style format. Dr. Tim Greenamyre has chaired the pilot project review process for the ADC. He is an experienced grant reviewer. He chairs the Grants and Fellowship Review Committee for the Huntington's Disease Society of America, serves on the Scientific advisory Board of the Michael J. Fox and the Parkinson Study Group, was a member of an NIH review panel (NSD-B), and on the Dystonia Medical Research Foundation Review Committee. The investigators propose that 4-5 independent scientists at the two other CCPDERs review the applications. As necessary, outside ad hoc reviews will be solicited to ensure appropriate expertise. The reviews will be asked to provide an overall rating (using an NIH rating system) and judge the scientific merit of the proposals, and their originally, soundness of design, and prospects for subsequent funding. Other factors begin equal, priority will be given to junior investigators or those who are new to the field. Reviews will be collected, averaged, and priority scores assigned. Proposals with the best scores will be funded. To assess progress, brief written reports (2-3 pages) will be required at 6 months and at completion of the pilot project. Reports will be reviewed by the CCPDER Executive Committee, and if deemed necessary, by the original Review Committee.

Agency
National Institute of Health (NIH)
Institute
National Institute of Environmental Health Sciences (NIEHS)
Type
Specialized Center--Cooperative Agreements (U54)
Project #
1U54ES012068-01
Application #
6669596
Study Section
Special Emphasis Panel (ZES1)
Project Start
2002-08-26
Project End
2007-07-30
Budget Start
Budget End
Support Year
1
Fiscal Year
2002
Total Cost
Indirect Cost
Name
Emory University
Department
Type
DUNS #
042250712
City
Atlanta
State
GA
Country
United States
Zip Code
30322
Richardson, Jason R; Taylor, Michele M; Shalat, Stuart L et al. (2015) Developmental pesticide exposure reproduces features of attention deficit hyperactivity disorder. FASEB J 29:1960-72
Bayir, Hülya; Kapralov, Alexandr A; Jiang, Janfei et al. (2009) Peroxidase mechanism of lipid-dependent cross-linking of synuclein with cytochrome C: protection against apoptosis versus delayed oxidative stress in Parkinson disease. J Biol Chem 284:15951-69
Qi, Zhen; Miller, Gary W; Voit, Eberhard O (2009) Computational analysis of determinants of dopamine (DA) dysfunction in DA nerve terminals. Synapse 63:1133-42
Evatt, Marian L; Delong, Mahlon R; Khazai, Natasha et al. (2008) Prevalence of vitamin d insufficiency in patients with Parkinson disease and Alzheimer disease. Arch Neurol 65:1348-52
Guillot, T S; Richardson, J R; Wang, M Z et al. (2008) PACAP38 increases vesicular monoamine transporter 2 (VMAT2) expression and attenuates methamphetamine toxicity. Neuropeptides 42:423-34
Qi, Zhen; Miller, Gary W; Voit, Eberhard O (2008) Computational systems analysis of dopamine metabolism. PLoS One 3:e2444
Betarbet, Ranjita; Anderson, Leah R; Gearing, Marla et al. (2008) Fas-associated factor 1 and Parkinson's disease. Neurobiol Dis 31:309-15
Marella, Mathieu; Seo, Byoung Boo; Nakamaru-Ogiso, Eiko et al. (2008) Protection by the NDI1 gene against neurodegeneration in a rotenone rat model of Parkinson's disease. PLoS One 3:e1433
Richardson, Jason R; Caudle, W Michael; Wang, Min Zheng et al. (2008) Developmental heptachlor exposure increases susceptibility of dopamine neurons to N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)in a gender-specific manner. Neurotoxicology 29:855-63
Xia, Qiangwei; Liao, Lujian; Cheng, Dongmei et al. (2008) Proteomic identification of novel proteins associated with Lewy bodies. Front Biosci 13:3850-6

Showing the most recent 10 out of 50 publications